Albert- as you seem to have some understanding of this process, so does this announcement mean CE approval is now a given pending an ok of the post market stuff? The quote from the CEO says the concerns from early in the year have been resolved so is it now fair to say BSI - COC has confirmed complete reversal of it’s previous position and is now saying yes there’s sufficient clinical benefit for device after all? Yes it’s fair to say I’m one of the doubters but I’m actually also genuinely interested to understand the nuances of the announcement. Thanks
OSL Price at posting:
14.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)